213,285 Orion Corporation A shares converted into B shares [Yahoo! Finance]
ORION CORP NEW UNSP/ADR (ORINY)
NASDAQ:AMEX Investor Relations:
orion.fi/en/orion-group/investors/investor-relations
Company Research
Source: Yahoo! Finance
20 SEPTEMBER 2024 at 9.30 EEST 213,285 Orion Corporation A shares converted into B shares In accordance with Section 3 of the Articles of Association of Orion Corporation, 213,285 A shares have been converted into 213,285 B shares. The conversion has been entered into the Trade Register on 20 September 2024. The total number of shares in Orion Corporation is 141,134,278 which, after the conversion, consists of 32,974,309 A shares and 108,159,969 B shares. The number of votes of the company's shares is after the conversion 767,646,149. Orion Corporation René Lindell CFO Olli Huotari SVP, Corporate Functions Contact person Tuukka Hirvonen, Investor Relations, tel. +358 10 426 2721 Publisher Orion Corporation Communications Orionintie 1A, FI-02200 Espoo, Finland http://www.orion.fi/en http://www.twitter.com/OrionCorpIR Orion is a globally operating Finnish pharmaceutical company – a builder of well-being for over a hundred years. We develop, manufacture
Show less
Read more
Impact Snapshot
Event Time:
ORINY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ORINY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ORINY alerts
High impacting ORION CORP NEW UNSP/ADR news events
Weekly update
A roundup of the hottest topics
ORINY
News
- Bayer Submits Supplemental New Drug Application to U.S. FDA Seeking Expanded Indication for NUBEQA® (darolutamide) in Metastatic Hormone-Sensitive Prostate Cancer [Yahoo! Finance]Yahoo! Finance
- Orion’s collaboration partner Bayer submits application to U.S. FDA for third indication of darolutamide which has become the first ever Orion-originated blockbusterGlobeNewswire
- Orion and Aitia enter AI-Driven Drug Discovery and Drug Simulation Collaboration in OncologyGlobeNewswire
- Inside information: Orion upgrades full-year outlook for 2024 [Yahoo! Finance]Yahoo! Finance
- 3 Reasons Why Growth Investors Shouldn't Overlook Orion OYJ (ORINY) [Yahoo! Finance]Yahoo! Finance